Overview:

Summary

GlobalData's clinical trial report, “Gaucher’s Disease Global Clinical Trials Review, Q1, 2011"" provides data on the Gaucher’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gaucher’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gaucher’s Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Gaucher's Disease 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Gaucher's Disease 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Gaucher's Disease Therapeutics Clinical Trials 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Amicus Therapeutics, Inc. 26
Clinical Trial Overview of Amicus Therapeutics, Inc. 26
Shire Plc 27
Clinical Trial Overview of Shire Plc 27
Sanofi-Aventis 28
Clinical Trial Overview of Sanofi-Aventis 28
Abbott Laboratories 29
Clinical Trial Overview of Abbott Laboratories 29
Genzyme Corporation 30
Clinical Trial Overview of Genzyme Corporation 30
Protalix Ltd. 31
Clinical Trial Overview of Protalix Ltd. 31
Shire Human Genetic Therapies, Inc. 32
Clinical Trial Overview of Shire Human Genetic Therapies, Inc. 32
ISU ABXIS Co.,Ltd. 33
Clinical Trial Overview of ISU ABXIS Co.,Ltd. 33
Protalix BioTherapeutics, Inc. 34
Clinical Trial Overview of Protalix BioTherapeutics, Inc. 34
Actelion Ltd 35
Clinical Trial Overview of Actelion Ltd 35
Clinical Trial Overview of Top Universities / Institutes / Hospitals 36
University Research Foundation for Lysosomal Storage Diseases, Inc. 36
Clinical Trial Overview of University Research Foundation for Lysosomal Storage Diseases, Inc. 36
University of Rostock 37
Clinical Trial Overview of University of Rostock 37
Masonic Cancer Center 38
Clinical Trial Overview of Masonic Cancer Center 38
Shaare Zedek Medical Center 39
Clinical Trial Overview of Shaare Zedek Medical Center 39
Nantes University Hospital 40
Clinical Trial Overview of Nantes University Hospital 40
Appendix 41
Abbreviations 41
Definitions 41
Research Methodology 42
Secondary Research 42
About GlobalData 43
Contact Us 43
Disclaimer 43
Source 44"

List of Tables
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Zone, 2011* 6
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Gaucher's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2011* 10
Gaucher's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 11
Gaucher's Disease Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Gaucher's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 13
Gaucher's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 14
Gaucher's Disease Therapeutics Clinical Trials, BRIC Countries, 2011* 15
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Phase, 2011* 16
Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 17
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Gaucher's Disease Therapeutics Market, Global, Terminated Clinical Trials, 2011* 19
Gaucher's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Gaucher's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Gaucher's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 24
Gaucher's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 25
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Amicus Therapeutics, Inc., 2011* 26
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2011* 27
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011* 28
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011* 29
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2011* 30
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Protalix Ltd., 2011* 31
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Human Genetic Therapies, Inc., 2011* 32
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by ISU ABXIS Co.,Ltd., 2011* 33
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Protalix BioTherapeutics, Inc., 2011* 34
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2011* 35
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Research Foundation for Lysosomal Storage Diseases, Inc., 2011* 36
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rostock, 2011* 37
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2011* 38
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2011* 39
Gaucher's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2011* 40"

List of Figures
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 6
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 7
Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Gaucher's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011* 10
Gaucher's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 11
Gaucher's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 12
Gaucher's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 13
Gaucher's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 14
Gaucher's Disease Therapeutics Clinical Trials, BRIC Countries (%), 2011* 15
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 16
Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 17
Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Gaucher's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Gaucher's Disease  Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Gaucher's Disease  Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Gaucher's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 25
GlobalData Methodology 42